Tom E. Verstraelen

726 citations

25 papers · 339 indexed · h-index 10

Co-authors: Arthur A.M. Wilde Aeilko H. Zwinderman Maarten P. van den Berg Paul A. van der Zwaag Rudolf A. de Boer Folkert W. Asselbergs Freyja H.M. van Lint Hidde Bleijendaal
Topics: Cardiac electrophysiology and arrhythmias (15 papers)Cardiomyopathy and Myosin Studies (13 papers)Cardiac pacing and defibrillation studies (11 papers)
Cited by: Cardiology and Cardiovascular Medicine Health Informatics Health Information Management
Journals: European Heart Journal Statistics in Medicine JACC. Cardiovascular imaging
Partner nations: Netherlands Germany United Kingdom

In The Last Decade

Tom E. Verstraelen

23 papers receiving 331 citations

Peers

Countries citing papers authored by Tom E. Verstraelen

Since Specialization

Citations

This map shows the geographic impact of Tom E. Verstraelen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom E. Verstraelen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom E. Verstraelen more than expected).

Fields of papers citing papers by Tom E. Verstraelen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tom E. Verstraelen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom E. Verstraelen. The network helps show where Tom E. Verstraelen may publish in the future.

Co-authorship network of co-authors of Tom E. Verstraelen

This figure shows the co-authorship network connecting the top 25 collaborators of Tom E. Verstraelen. A scholar is included among the top collaborators of Tom E. Verstraelen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tom E. Verstraelen. Tom E. Verstraelen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The role of comorbidities and lifestyle factors in disease progression of phospholamban cardiomyopathy 2025 ·European Journal of Preventive Cardiology ·(unknown),(unknown),Moniek G.P.J. Cox,Tom E. Verstraelen,Remco de Brouwer,(unknown),Arjan C. Houweling,Anneline S.J.M. te Riele,Rudolf A. de Boer,B. Daan Westenbrink,Arthur A.M. Wilde	1
2	Personalized sudden cardiac death risk prediction in genetic heart diseases: Beyond one-size-fits-all 2025 ·Heart Rhythm ·(unknown),Tom E. Verstraelen,(unknown)	0
3	ECG-only explainable deep learning algorithm predicts the risk for malignant ventricular arrhythmia in phospholamban cardiomyopathy 2024 ·Heart Rhythm ·Rutger R van de Leur,Remco de Brouwer,Hidde Bleijendaal,Tom E. Verstraelen,(unknown),(unknown),(unknown),(unknown),Tjeerd Germans,Arjan C. Houweling,Paul A. van der Zwaag,Moniek G.P.J. Cox,(unknown),Anneline S.J.M. te Riele,Maarten P. van den Berg,(unknown),(unknown),Rudolf A. de Boer,René van Es	9
4	Assessment of ICD eligibility in non-ischaemic cardiomyopathy patients: a position statement by the Task Force of the Dutch Society of Cardiology 2024 ·Netherlands Heart Journal ·Anne‐Lotte C.J. van der Lingen,Tom E. Verstraelen,Lieselot van Erven,Joan G. Meeder,Dominic A.M.J. Theuns,Kevin Vernooy,Arthur A.M. Wilde,Alexander H. Maass,Cornelis P. Allaart	2
5	Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study 2024 ·EP Europace ·(unknown),Tom E. Verstraelen,Freyja H.M. van Lint,(unknown),Remco de Brouwer,Virginnio Proost,(unknown),Karim Taha,Aeilko H. Zwinderman,(unknown),B. A. Schoonderwoerd,Tjeerd Germans,Arjan C. Houweling,Juan R. Gimeno,Paul A. van der Zwaag,Rudolf A. de Boer,Moniek G.P.J. Cox,J. Peter van Tintelen,Arthur A.M. Wilde	8
6	Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy 2023 ·Netherlands Heart Journal ·Freyja H.M. van Lint,(unknown),Tom E. Verstraelen,Weijia Wang,Laurens P. Bosman,Paul A. van der Zwaag,(unknown),Hugh Calkins,Brittney Murray,Crystal Tichnell,(unknown),Folkert W. Asselbergs,Arjan C. Houweling,Maarten P. van den Berg,Arthur A.M. Wilde,Cynthia A. James,J. Peter van Tintelen	13
7	Deep neural network-based clustering of deformation curves reveals novel disease features in PLN pathogenic variant carriers 2023 ·The International Journal of Cardiovascular Imaging ·Karim Taha,Rutger R van de Leur,(unknown),Thomas P. Mast,Maarten J. Cramer,Nicholas Cauwenberghs,Tom E. Verstraelen,Remco de Brouwer,Pieter A. Doevendans,Arthur A.M. Wilde,Folkert W. Asselbergs,Maarten P. van den Berg,Jan D’hooge,Tatiana Kuznetsova,Arco J. Teske,René van Es	2
8	Implantable defibrillator therapy and mortality in patients with non-ischaemic dilated cardiomyopathy 2022 ·Netherlands Heart Journal ·Dominic A.M.J. Theuns,Tom E. Verstraelen,(unknown),Peter Paul H.M. Delnoy,Cor Allaart,(unknown),Alexander H. Maass,Kevin Vernooy,A. A. M. Wilde,Eric Boersma,(unknown)	5
9	Exploring the Correlation Between Fibrosis Biomarkers and Clinical Disease Severity in PLN p.Arg14del Patients 2022 ·Frontiers in Cardiovascular Medicine ·(unknown),Mimount Bourfiss,Anneline S.J.M. te Riele,Karim Taha,Marc A. Vos,Remco de Brouwer,Tom E. Verstraelen,Rudolf A. de Boer,Carol Ann Remme,Toon A.B. van Veen	8
10	Hospital utilisation and the costs associated with complications of ICD implantation in a contemporary primary prevention cohort 2022 ·Netherlands Heart Journal ·(unknown),Tom E. Verstraelen,Erik Buskens,Pascal F.H.M. van Dessel,Lucas V.A. Boersma,Peter Paul H.M. Delnoy,Anton E. Tuinenburg,Dominic A.M.J. Theuns,Pepijn H. van der Voort,(unknown),Aeilko H. Zwinderman,Arthur A.M. Wilde,Marcel G. W. Dijkgraaf,(unknown),(unknown),(unknown),(unknown),(unknown)	4
11	A failed catheter ablation of atrial fibrillation is associated with more advanced remodeling and reduced efficacy of further thoracoscopic ablation 2022 ·Revista Española de Cardiología (English Edition) ·Robin Wesselink,(unknown),Ingrid Overeinder,Jolien Neefs,(unknown),Eva R. Meulendijks,Femke R. Piersma,(unknown),(unknown),Tom E. Verstraelen,(unknown),Bart Maesen,Carlo de Asmundis,Gian‐Battista Chierchia,Mark La Meir,Laurent Pison,Wim Jan van Boven,Antoine H.G. Driessen,Joris R. de Groot	1
12	The β-angle can help guide clinical decisions in the diagnostic work-up of patients suspected of Brugada syndrome: a validation study of the β-angle in determining the outcome of a sodium channel provocation test 2021 ·EP Europace ·Martijn H. van der Ree,Jeroen Vendrik,Tom E. Verstraelen,Jan A. Kors,Ahmad S. Amin,Arthur A.M. Wilde,Hanno L. Tan,Pieter G. Postema	5
13	Dutch Outcome in Implantable Cardioverter‐Defibrillator Therapy: Implantable Cardioverter‐Defibrillator–Related Complications in a Contemporary Primary Prevention Cohort 2021 ·Journal of the American Heart Association ·(unknown),Tom E. Verstraelen,Pascal F.H.M. van Dessel,Lucas V.A. Boersma,Peter Paul H.M. Delnoy,Anton E. Tuinenburg,Dominic A.M.J. Theuns,Pepijn H. van der Voort,(unknown),Erik Buskens,Aeilko H. Zwinderman,Arthur A.M. Wilde,Marcel G. W. Dijkgraaf,(unknown)	13
14	Sex-specific aspects of phospholamban cardiomyopathy: The importance and prognostic value of low-voltage electrocardiograms 2021 ·Heart Rhythm ·Remco de Brouwer,Laura M.G. Meems,Tom E. Verstraelen,(unknown),Virginnio Proost,Arthur A.M. Wilde,Laurens P. Bosman,(unknown),Paul A. van der Zwaag,J. Peter van Tintelen,Arjan C. Houweling,Maarten P. van den Berg,Rudolf A. de Boer	9
15	Improving electrocardiogram-based detection of rare genetic heart disease using transfer learning: An application to phospholamban p.Arg14del mutation carriers 2021 ·Computers in Biology and Medicine ·(unknown),Hidde Bleijendaal,Lucas A. Ramos,Tom E. Verstraelen,Ahmad S. Amin,Arthur A.M. Wilde,Yigal M. Pinto,Bas A.J.M. de Mol,Henk A. Marquering	40
16	Early Mechanical Alterations in Phospholamban Mutation Carriers 2020 ·JACC. Cardiovascular imaging ·Karim Taha,Wouter P. te Rijdt,Tom E. Verstraelen,Maarten J. Cramer,Rudolf A. de Boer,Rianne H.A.C.M. de Bruin‐Bon,Berto J. Bouma,Folkert W. Asselbergs,Arthur A.M. Wilde,Maarten P. van den Berg,Arco J. Teske	13
17	Computer versus cardiologist: Is a machine learning algorithm able to outperform an expert in diagnosing a phospholamban p.Arg14del mutation on the electrocardiogram? 2020 ·Heart Rhythm ·Hidde Bleijendaal,Lucas A. Ramos,(unknown),Tom E. Verstraelen,Sarah W.E. Baalman,(unknown),Fleur V.Y. Tjong,(unknown),Francisco-Javier Gimeno-Blanes,Juan R. Gimeno,Ahmad S. Amin,Michiel M. Winter,Henk A. Marquering,Wouter E.M. Kok,Aeilko H. Zwinderman,Arthur A.M. Wilde,Yigal M. Pinto	36
18	The Netherlands Arrhythmogenic Cardiomyopathy Registry: design and status update 2019 ·Netherlands Heart Journal ·(unknown),Laurens P. Bosman,Tom E. Verstraelen,Freyja H.M. van Lint,Moniek G.P.J. Cox,Judith A. Groeneweg,Thomas P. Mast,Paul A. van der Zwaag,(unknown),Reinder Evertz,(unknown),Natasja M.S. de Groot,Katja Zeppenfeld,Jeroen F. van der Heijden,Maarten P. van den Berg,A. A. M. Wilde,Folkert W. Asselbergs,Richard N.W. Hauer,Anneline S.J.M. te Riele,J. Peter van Tintelen	29
19	Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillator 2017 ·Netherlands Heart Journal ·(unknown),(unknown),Marcel G. W. Dijkgraaf,Michiel Hulleman,Lucas V.A. Boersma,Peter Paul H.M. Delnoy,Mathias Meine,Anton E. Tuinenburg,Dominic A.M.J. Theuns,Pepijn H. van der Voort,(unknown),Erik Buskens,Jan Tijssen,Nienke Bruinsma,Tom E. Verstraelen,Aeilko H. Zwinderman,Pascal F.H.M. van Dessel,Arthur A.M. Wilde	6
20	The role of the SCN 5A ‐encoded channelopathy in irritable bowel syndrome and other gastrointestinal disorders 2015 ·Neurogastroenterology & Motility ·Tom E. Verstraelen,Rachel M.A. ter Bekke,Paul G.A. Volders,Ad Masclee,Joanna W. Kruimel	20

About Tom E. Verstraelen

Tom E. Verstraelen is a scholar working on Cardiology and Cardiovascular Medicine, Gastroenterology and Statistics and Probability, having authored 25 papers that have together received 339 indexed citations. Recurring topics across this work include Cardiac electrophysiology and arrhythmias (15 papers), Cardiomyopathy and Myosin Studies (13 papers) and Cardiac pacing and defibrillation studies (11 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (249 citations), Health Informatics (8 citations) and Health Information Management (15 citations). Tom E. Verstraelen has collaborated with scholars based in Netherlands, Germany and United Kingdom. Frequent co-authors include Arthur A.M. Wilde, Aeilko H. Zwinderman, Maarten P. van den Berg, Paul A. van der Zwaag, Rudolf A. de Boer, Folkert W. Asselbergs, Freyja H.M. van Lint, Hidde Bleijendaal, Laurens P. Bosman and Lucas A. Ramos. Their work appears in journals such as European Heart Journal, Statistics in Medicine and JACC. Cardiovascular imaging.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact